Showing 1 - 10 results of 10 for search 'L. Yu. Milovanova', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor... by L Yu Milovanova, L V Kozlovskaya, Yu S Milovanov, I N Bobkova, I A Dobrosmyslov
Published 2010-06-01
Article -
5
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chron... by N A Mukhin, Yu S Milovanov, L V Kozlovskaya, I A Dobrosmyslov, L Yu Milovanova
Published 2016-04-01
Article -
6
-
7
Quality of life of chronic kidney disease patients on renal replacement therapy by Yu S Milovanov, I A Dobrosmyslov, S Yu Milovanova, M V Taranova, L Yu Milovanova, V V Fomin, V V Kozlov
Published 2018-06-01
Article -
8
-
9
Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD... by L Yu Milovanova, I A Dobrosmyslov, Yu S Milovanov, V V Fomin, M V Taranova, V V Kozlov, S Yu Milovanova, E I Kozevnikova
Published 2018-06-01
Article -
10
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney di... by L Yu Milovanova, Yu S Milovanov, D V Kudryavtseva, M M Markina, S Yu Milovanova, L V Kozlovskaya, M V Lebedeva, V D Beketov, S V Moiseev, N A Mukhin, V V Fomin, A A Svistunov
Published 2015-06-01
Article